IL6 and breast carcinoma: The results of the current study confirm that 1,25(OH)2D inhibits the migratory potential of breast cancer cells and that this may be due in part to an indirect mechanism—by altering adipocyte release of chemoattractants, such as leptin, adiponectin, IL-6, and IGF-1.